The 2 Million Access Guideline!
Incredibly, the 2022 edition reached 2.1 million hits since the beginning of April 2022. A year has passed and SBD celebrates this resounding success, showing that the option for digital, the flow of information, the quality of peer-review, by the transparency of the evidence makes all the difference. Health professionals working with diabetes know that the search for evidence is the essence of serious work and that they need to make their decisions based on the best of the scientific literature.
The 2023 guideline brings more. There are 12 new chapters written in the same style and submitted to the same rigorous peer-review by the central committee. New chapters have been revised and diagrammed. Some sections have been rescheduled. The amount of information has increased substantially. We have two important chapters on the management of hospitalized patients with diabetes, the approach to the elderly with diabetes, the prevention of diabetic foot ulcers, peculiarities of the treatment of children with type 1 diabetes, management of sick days in DM1, management of hypogonadism in patient with diabetes, among others. We have not forgotten the colleagues who work at SUS with a version adapted by the SBD for the most important PCDTs related to the treatment of DM1 and DM2. In addition, some chapters have been revised and updated.
Incredibly, the 2022 edition reached 2.1 million hits since the beginning of April 2022. A year has passed and SBD celebrates this resounding success, showing that the option for digital, the flow of information, the quality of peer-review, by the transparency of the evidence makes all the difference. Health professionals working with diabetes know that the search for evidence is the essence of serious work and that they need to make their decisions based on the best of the scientific literature.
The 2023 guideline brings more. There are 12 new chapters written in the same style and submitted to the same rigorous peer-review by the central committee. New chapters have been revised and diagrammed. Some sections have been rescheduled. The amount of information has increased substantially. We have two important chapters on the management of hospitalized patients with diabetes, the approach to the elderly with diabetes, the prevention of diabetic foot ulcers, peculiarities of the treatment of children with type 1 diabetes, management of sick days in DM1, management of hypogonadism in patient with diabetes, among others. We have not forgotten the colleagues who work at SUS with a version adapted by the SBD for the most important PCDTs related to the treatment of DM1 and DM2. In addition, some chapters have been revised and updated.
Show More
